Sandoz agrees to $275 million settlement in US multistate litigation over inflated drug prices
MLex Summary: Sandoz has agreed to a $275 million settlement with end payers to resolve allegations that it conspired to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade...To view the full article, register now.
Already a subscriber? Click here to view full article